Abstract: Polyglycerol carboxylic acid esters are made by reaction of a, typically C2 to C30, particularly C6 to C22. carboxylic acid with glycerol carbonate, particularly with base catalyst, and desirably at temperatures from 170° C. to 250° C. Other carbonates e.g. cyclic diol carbonates such as ethylene or propylene carbonates, may be used in combination with the glycerol carbonate to make novel mixed polymeric esters. The molar ratio of carboxylic acid group to glycerol carbonate is typically from 2 to 30, but can be up to 100. The base catalyst is desirably alkali metal hydroxide, carbonate or alkoxide. The reaction is desirably carried out in an inert atmosphere, and reducing agent such as phosphorous acid, hypophosphorous acid or borohydride and/or activated carbon, may be included to improve product colour.

Abstract: Derivative compounds of 11-nonyloxy-undec-8(Z)-eonic acid that mimic epoxide metabolites are provided. Also provided are compositions comprising a therapeutically effective amount of the derivative compounds. The present invention further provides methods for the use of such compositions for the treatment of renal or cardiovascular disease and/or related conditions.

Abstract: Polyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.

Abstract: The present invention relates to a polyglycerol significantly reduced in content of a polyglycerol having a cyclic structure formed by removal of a water molecule from a polyglycerol molecule, and to a fatty acid ester of a polyglycerol having excellent surface activity. 2 mole or more of glycidol and a catalyst are successively added to 1 mole of glycerol for a reaction to obtain a polyglycerol, in which a ratio of [total polyglycerol (1)] to [total polyglycerol (2) having a cyclic structure] is [70% or more]/[30% or less] (the total of both is 100% by weight) in terms of an intensity ratio determined by liquid chromatography/mass spectrometry; and an average polymerization degree “n” is 2 or more. A reaction of a polyglycerol with a fatty acid provides the corresponding a fatty acid ester of the polyglycerol.

Abstract: A phase change ink including a colorant and a carrier including a tri-ester of the formula wherein R1, R2 and R3, and n are as defined herein.

Abstract: There is provided a compound of the formula (I) wherein R1 is an alkyl, alkenyl or alkynyl group containing x carbon atoms, wherein x is from 1 to 10, wherein one of R2 and R3 is an alkyl, alkenyl or alkynyl group containing y carbon atoms, wherein y is from 1 to 10, wherein the other of R2 and R3 is a branched group of the formula (II) wherein q is from 0 to 3, wherein each R5 is independently selected from —OH and —O—C(O)—R4, wherein n is from 10 to 20 and m is selected from 2n-q, 2n-2-q, 2n-4-q, and 2n-6-q, wherein each R4 is independently selected from alkyl, alkenyl and alkynyl groups containing z carbon atoms, wherein z is from 7 to 21, wherein z is different to at least one of x and y.

Abstract: Novel nitric-oxide releasing lipid molecules are provided which comprise a lipid molecule selected from (a) phosphoglycerides, (b) lipids having a sphingosine base as a backbone, (c) monoacylglyerols, (d) diacylglycerols, (e) glycosylacylglycerols, and (f) sterol compounds of the formula: where R is a branched aliphatic chain of eight or more carbon atoms, wherein the lipid molecule is provided with a nitric-oxide containing group which comprises (a) a —S—N?O moiety, (b) a —O—N?O moiety, or (c) a moiety. Also provided are methods of forming such nitric oxide releasing lipid molecules. Various pharmaceutical compositions, topical liquids and drug delivery systems comprising the nitric-oxide releasing lipid molecules are also described.

Abstract: An aldehyde composition containing a mixture of mono-formyl-, diformyl-, and triformyl-substituted fatty acids and/or fatty acid esters having a di-aldehyde/tri-aldehyde weight ratio of less than 5/1 and an average functionality number from greater than 0.96 to less than 1.26. A monomer alcohol composition containing a mixture of mono-hydroxymethyl-, dihydroxymethyl-, and trihydroxymethyl-substituted fatty acids and/or fatty acid esters having a diol/triol weight ratio of less than 5/1 and an average functionality number from greater than 0.90 to less than 1.20. The monomer alcohol can be converted into an oligomeric polyol for use in the manufacture of polyurethane flexible foams.

Abstract: A novel series of compositions with aqueous chemicals decontamination activity and their uses is described. The preparation of esters of fatty acids with polyols that contain lactic acid is also described. These novel compositions release hydroxy acid and fatty acids slowly into water providing activity over long periods of time with the compounds exhibiting biodegradable characteristics and aiding in the biodegradation of contaminants.

Abstract: Long-chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field.

Abstract: A method of forming a biodiesel product and a heterogeneous catalyst system used to form said product that has a high tolerance for the presence of water and free fatty acids (FFA) in the oil feedstock is disclosed. This catalyst system may simultaneously catalyze both the esterification of FAA and the transesterification of triglycerides present in the oil feedstock. The catalyst system according to one aspect of the present disclosure represents a class of zinc and lanthanum oxide heterogeneous catalysts that include different ratios of zinc oxide to lanthanum oxides (Zn:La ratio) ranging from about 10:0 to 0:10. The Zn:La ratio in the catalyst is believed to have an effect on the number and reactivity of Lewis acid and base sites, as well as the transesterification of glycerides, the esterification of fatty acids, and the hydrolysis of glycerides and biodiesel.

Abstract: Processes for preparation of fatty acid alkyl esters are described herein. The processes include contacting fatty acid glycerides with alcohols in the presence of a catalyst separating the reaction products from the catalyst, and separating the fatty acid alkyl esters from the reaction products. The catalyst includes a metal from Group VIB of the Periodic Table, a metal from Group IIIA of the Periodic Table, and an element from Group VA of the Periodic Table.

Abstract: A polyglycerol fatty acid ester formed by esterifying a polyglycerol and a fatty acid, wherein the polyglycerol has a hydroxyl value of 1200 or less and primary hydroxyl groups in an amount of 50% or more of the total hydroxyl groups, and an emulsified or solubilized composition, foodstuff, and cosmetics, each containing the polyglycerol fatty acid ester.

Abstract: An improved pasteurisation protocol for pasteurising microbial cells is disclosed. The protocol has three stages, a first heating stage, a second plateau stage at which the cells are held at a (maximum and) constant temperature, and a third cooling stage. Both the heating and the cooling stages are rapid, with the temperature of the cells passing through 40 to 80° C. in no more than 30 minutes in the heating stage. The heating rate is at least 0.5° C./minute and during cooling is at least ?0.5° C./minute. The plateau maximum temperature is from 70 to 85° C. By plotting the pasteurisation protocol on a time (t, minutes) versus temperature (T, ° C.) graph, one obtains a trapezium having an area less than 13,000° C. minute. Not only does this result in a smaller energy input (and so a reduction in costs), but a better quality (and less oxidised) oil results having a peroxide value (POV) of less than 1.5 and an anisidine value (AnV) of less than 1.0.

Abstract: The present invention provides novel gene constructs and methods for the production of transgenic cotton plants that produce oils having a range of desirable attributes, including improved oil quality, and modified fatty acid composition.

Abstract: Bioabsorbable macromer compositions are provided including a polymeric component possessing a lipid segment which enhances the affinity of the macromer composition to targeted tissue. In some embodiments, the polymeric component can be combined with a second component. The resulting bioabsorbable macromer composition can be employed as an adhesive or sealant for medical/surgical uses.

Abstract: Disclosed is a base agent for electrical insulating oils, which mainly contains an esterified product of glycerin and a linear or branched, saturated or unsaturated fatty acid having 6-14, preferably 8-12 carbon atoms. This base agent for electrical insulating oils is excellent in electrical characteristics, oxidation stability, cooling characteristics, flame retardance and safety. In particular, this agent for electrical insulating oils can meet energy/environmental problems by using an edible oil and fat, which is obtained by using a fatty acid derived from a vegetable oil as a raw material, as the linear or branched, saturated or unsaturated fatty acid having 6-14 carbon atoms.

Abstract: The invention relates to the use in food products, such as spreads, sauces, ice-cream, soups, bakery products, and confectionery products, and cosmetic products, such as creams, lotions, lipsticks, soap bars, and skin or hair oils, of an oil having an oleic acid content of more than 40 wt % and a stearic acid content of more than 12 wt % based on the total fatty acid content of said oil, and wherein a maximum of 10 wt % of the fatty acid groups in the stereospecifically numbered-2 position of the triacylglycerol molecules constituting the oil are saturated fatty acid groups.

Abstract: The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), cyclooxygenase-II (COX-2) and an analgesic, such as aspirin (ASA). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy EPA or DHA compounds having unique structural and physiological properties. The present invention therefore provides for many new useful therapeutic di- or tri-hydroxy derivatives of EPA or DHA (resolvins) that diminish, prevent, or eliminate inflammation or PMN migration, for example. The present invention also provides methods of use, methods of preparation, and packaged pharmaceuticals for use as medicaments for the compounds disclosed throughout the specification.

Abstract: Disclosed are petrolatum-like compositions that comprise metathesized unsaturated polyol esters. Also disclosed are emulsions comprising metathesized unsaturated polyol esters. The petrolatum-like compositions may be used as substitutes for petroleum-based petrolatum. The emulsions may be water-in-oil or oil-in-water emulsions and may be suitable for a variety of end uses.

Abstract: Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.

Abstract: The present invention is drawn to a process for providing emolliency to the skin using a series so called “spider esters”. These esters are derived from poly-hydroxy functional compounds sequentially reacted with ethylene oxide or propylene oxide, followed by the reaction of the alkoxylate with fatty acid. The resulting products are called spider esters because they resemble the spider, wherein appendages are alkoxylated esters. The restrictions this orientation imposes on rotation allows for the preparation of polar esters that have little or no water solubility, and provide both moisturization to the skin and emolliency by reducing transepidermal water loss.

Abstract: The invention relates to a sunflower seed, comprising sunflower oil having increased stearic acid content as compared to wild type seeds (preferably between 19.1 and 35% by weight related to the total amount of fatty acids in the oil and comprising in the oil at least 3.4% of the triacylglycerol species that have the general formula SMS and not more than 5-0% of triacylglycerol species that have the general formula SMM obtainable by treating parent seeds with a mutagenic agent during a period of time and in a concentration sufficient to induce one or more mutations in the genetic trait involved in stearic acid biosynthesis resulting in increased production of stearic acid, germinating the treated seeds and culturing progeny plants therefrom, collecting and analyzing progeny seeds, selecting seeds that have acquired the desirable genetic traits and optionally repeating the cycle of germination, culturing and collection of seeds.

Abstract: The invention relates to a compound which is an ester of 1,2,3-propanetriol with one or more C11 to C24 fatty acids, wherein at least one fatty acid has at least one double bond. The compound is useful in the treatment of chronic inflammatory disorders.

Abstract: The present invention relates to compositions comprising acyltransferase nucleic acid molecules for altering lipids on the surface of plants, and related methods. In particular, the present invention provides compositions and methods for increasing the amount of free fatty acids, acylglycerols, and other lipids on the surface of a plant. In a preferred embodiment, the present invention relates to increasing activity of a GPAT acyltransferase for altering lipid on the plant surface, for increasing surface lipids, for enhancing environmental stress tolerance, increasing resistance to biotic stress, and providing novel plant lipids for commercial products. In further embodiments, the present invention relates to using an Arabidopsis thaliana GPAT acyltransferase for altering lipid compounds on the surface of a plant.

Abstract: Novel alkoxylates prepared by the reaction of mild-processed shea butter (MPSB) with ethylene oxide, propylene oxide or mixtures thereof. These compounds are useful as cosmetic and personal care ingredients, allowing for the delivery of highly desirable active ingredients present in MPSB, including natural antioxidants, in a water-soluble form that is substantive to the skin and hair.

Abstract: The present invention relates to sunflower seeds which have been genetically modified through two artificial induction cycles of mutations followed in each case by processes for the identification of mutant individuals which have the desired character. The disclosed seeds are characterised in that they contain between 26% and 80% of the tocopherols as delta-tocopherol. This high delta-tocopherol production is determined by the genotype of the seeds which have been modified to this effect, and is always obtained independently of the culture conditions, thereby obtaining an inheritable character. Today, sunflower seeds producing such high levels of delta-tocopherol do not exist. Genetically modified sunflower plants which produce through self-fertilization seeds with high delta-tocopherol levels and the oil with high natural delta-tocopherol concentration, extracted from the seeds, are also objectives of the present invention.

Abstract: The present invention relates to the use of polyesters which consist of at least one carbohydrate and at least one carboxylic acid, and mixtures thereof, as a hydraulic fluid.

Abstract: A method for the cationic polymerization of unsaturated biological oils (e.g., vegetable oils and animal oils) based on the cationic reaction of double bonds initiated by superacids is provided. The process occurs under very mild reaction conditions (about 70-110° C. and atmospheric pressure) and with short reaction times. The polymerized oils have a viscosity about 10 to 200 times higher than the initial oil and relatively high unsaturation (only about 10-30% lower than that of initial oils).

Abstract: By this invention, methods to produce oleic fatty acids in plant seed oils are provided. The methods of the present invention generally involve the suppression of a host plant cells endogenous ?-ketoacyl-ACP synthase I protein. Also described in the instant invention are the plants, cells and oils obtained therefrom.

Abstract: New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene/alkyl polyoxyalkylene chain with a chain-length of 25-455 repeating units and a specified substituent on the hydroxy position of the specified hydroxy fatty acid, according to the general formula (I) CH3—(CH2)x—CH—(CH2)y—CO—[—O—R3—]z—O—R1 R2—O (I); wherein for example R1 is methyl, R2 is optionally substituted C14-C22 acyl, alkyl, or alkenyl, R3 is ethylene, x is 2-12, y is 7-17, (x+y) is 3-19 and z is 25-57; advantageously prepared by involving an enzymatic process, formulations comprising them, their use as solubilizers and a process involving a hydrolytic enzyme for preparing them.

Abstract: A shortening system, such as a spray shortening system; for instance, a shortening system containing unhydrogenated or non-hydrogenated vegetable oil, such as a highly unsaturated, non-hydrogenated or unhydrogenated vegetable oil, e.g., soybean oil or canola oil and a minimum or minor amount (e.g., by weight about 3-10%, advantageously about 3-7%, more advantageously about 3-6% or about 3-5% or less than about 6% or less than about 8%) of conserved trans monoglyceride and/or diglyceride, advantageously a monoglyceride or a mono- and diglyceride that is mostly monoglyceride, based on a highly unsaturated oil, such as a highly unsaturated vegetable oil, e.g.

Abstract: A polyglycerol fatty acid ester formed by esterifying a polyglycerol and a fatty acid, wherein the polyglycerol has a hydroxyl value of 1200 or less and primary hydroxyl groups in an amount of 50% or more of the total hydroxyl groups, and an emulsified or solubilized composition, foodstuff, and cosmetics, each containing the polyglycerol fatty acid ester.

Abstract: The present invention is drawn to a process for providing emolliency to the skin using a series so called “spider esters”. These esters are derived from poly-hydroxy functional compounds sequentially reacted with ethylene oxide or propylene oxide, followed by the reaction of the alkoxylate with fatty acid. The resulting products are called spider esters because they resemble the spider, wherein appendages are alkoxylated esters. The restrictions this orientation imposes on rotation allows for the preparation of polar esters that have little or no water solubility, and provide both moisturization to the skin and emolliency by reducing transepidermal water loss.

Abstract: The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. Also, the invention encompasses compounds of the formula: A-X-Y-Z-R1 wherein A is a carboxy group or is absent; X is a polyol, Y is —C(?O)—, —C(?S)—, or is absent; Z is O, S, or NH; and R1 is a polyether, wherein one or more hydroxy groups of the polyol are acylated with a fatty acid residue, wherein the compounds form micelle assemblies. The invention encompasses methods of encapsulating molecules using the compounds of the invention.

Abstract: A branched ester composition obtainable by the reaction of a carboxylic acid with a branched alcohol composition under esterification reaction conditions wherein the branched alcohol composition has from about 8 to about 36 carbon atoms and an average number of branches per molecule of from about 0.7 to about 3.0, said branching comprising methyl and ethyl branches. The present invention further relates to personal care compositions for topical application to the skin or hair comprising said branched ester composition. The branched ester composition of the invention provides improved formulation flexibility.

Abstract: The invention relates to plant seeds that contain an oil having an oleic acid content of more than 40 wt % and a stearic acid content of more than 12 wt % based on the total fatty acid content of said oil, and wherein a maximum of 10 wt % of the fatty acid groups in the sn-2 position of the TAG molecules constituting the oil are saturated fatty acid groups. The invention also relates to plants that can be grown from the seeds, oil that can be extracted from the seeds, and to methods for obtaining the seeds, plants and oil.

Abstract: A mixture containing fatty acid glycerides which has a high percentage content of PUFA acyl groups and a low percentage content of saturated fatty acid acyl groups is described. A process which enables the PUFA acyl groups in a mixture containing fatty acid glycerides (for example a fish oil) to be enriched and, at the same time, the content of saturated fatty acid acyl groups to be maintained at a low content is described. The process is a hydrolytic process or an alcoholysis in which the fatty acid acyl groups to be enriched are hydrolytically or alcoholytically released from the fatty acid glycerides slowly, if at all, the process being carried out in the presence of a lipase.

Abstract: The invention provides a fuel additive compound represented by the general formula (I) wherein n is zero or an integer from 1 to 20 and in each succinic acid moiety one of R1 and R3 is a C3—C80 internal olefin moiety, and the other of R1 and R3 is hydrogen. Additive compositions containing such compounds have low viscosity and are useful in increasing the lubricity of middle distillate fuels.

Abstract: A process for enriching and separating polyunsaturated fatty acid (PUFA) acyl groups in a fatty acid mixture, which mixture contains other non-PUFA fatty acid acyl groups, is disclosed.

Abstract: A glyceride compound comprising a first aliphatic group and a first substituent group bonded to said first aliphatic group. The first substituent group has the formula —O(CH2CH2O)nP where n is 1 to 14 and P is a polymerisable group. An aqueous emulsion of the glyceride can be used in an emulsion polymerisation reaction to yield a polymer resin, which can then be mixed with a suitable base material, such as wood strands, to produce a composite material, such as Oriented Strand Board.

Abstract: The invention provides a process, for producing fats or oils in which the rate of triglycerides constituted by the same polyunsaturated fatty acids linking to the three hydroxyl groups of glycerol is 20% or more by weight for the total triglycerides, which comprises culturing a microorganism capable of producing said fats or oils and if required recovering said fats or oils; fats or oils produced by this process; and a process for producing said fats or oils.

Abstract: The present invention describes compounds produced from a creatine molecule and a fatty acid molecule. The compounds being in the form of creatine-fatty acid compounds being bound by an anhydride linkage, or mixtures thereof made by reacting creatine or derivatives thereof with an appropriate fatty acid previously reacted with a thionyl halide. The administration of such molecules provides supplemental creatine with enhanced bioavailability and the additional benefits conferred by the specific fatty acid.

Abstract: This invention is a composition that includes a transesterified fatty acid ester resulting from the reaction of a fatty acid ester, in the presence of an acid, with a hydroxyl-containing compound. The fatty acid esters of the invention are selected from those with a carbon number of eight to twenty. The hydroxyl-containing compound is an alcohol having a carbon number between one and eighteen. The resulting composition is useful as a lubricant, as a heat transfer agent, as a rheological modifier and as a corrosion/moisture inhibitor, among other uses.

Abstract: Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.

Abstract: The present invention relates to compositions which comprise mixtures of open-chain and cyclic molecules of the sugar alcohols D-sorbitol and D-mannitol which have been esterified with at least one carboxylic acid, processes for preparing these compositions and the use of this composition as lubricant or hydraulic liquid.

Abstract: A personal care or cosmetic product composition that includes from about 0.1% to about 99% of at least one ester of alkoxylated aromatic alcohol and fatty carboxylic acid, and from about 0.1% to 60% of at least one functional ingredient is provided. The functional ingredients in the composition may include active ingredients and additional ingredients. Especially suitable active ingredients are sunscreen active ingredients and antiperspirant active ingredients. Preferred compositions are sunscreen product formulations and antiperspirant products. In one preferred embodiment, the composition further includes at least one cyclomethicone compound present in the amount of from about 1% to 99% by weight of the composition. A method of improving the protection of human or animal skin or hair from radiation and a method of improving the protection of human or animal skin or hair from perspiration are also provided.

Abstract: The invention relates to a process for the preparation of methionine of high bulk density, in which a mixture which comprises a compound which has a foaming action and a compound which influences the crystallization is added to the hydrolysis solution, and to the mixture itself.

Abstract: The invention relates to compounds of formula: wherein R1 is selected from the group consisting of fatty acid acyl groups of 12 to 30 carbon atoms and fatty alcohol groups of 12 to 30 carbon atoms, and wherein R2 is selected from the group consisting of H, fatty acid acyl of 12 to 30 carbon atoms and fatty alcohol groups of 12 to 30 carbon atoms, the same as or different from R1, and the residue of a nutrient, drug, or other bioactive compound, and to the use of these compounds to deliver drugs and other bioactive compounds.

Abstract: The invention relates to compounds of formula: wherein R1 is selected from the group consisting of fatty acid acyl groups of 12 to 30 carbon atoms and fatty alcohol groups of 12 to 30 carbon atoms, and wherein R2 is selected from the group consisting of H, fatty acid acyl of 12 to 30 carbon atoms and fatty alcohol groups of 12 to 30 carbon atoms, the same as or different from R1, and the residue of a nutrient, drug, or other bioactive compound, and to the use of these compounds to deliver drugs and other bioactive compounds.